Home/Filings/4/0001104659-21-020987
4//SEC Filing

Fehlner Paul 4

Accession 0001104659-21-020987

CIK 0001633070other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 9:27 PM ET

Size

7.9 KB

Accession

0001104659-21-020987

Insider Transaction Report

Form 4
Period: 2021-02-09
Fehlner Paul
SVP & Chief IP Officer
Transactions
  • Award

    Restricted Stock Units

    2021-02-09+42,50042,500 total
    Common Stock (42,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-02-09+85,00085,000 total
    Exercise: $6.59Exp: 2031-02-08Common Stock (85,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of AXLA common stock.
  • [F2]The restricted stock units vest as follows: 1/3 of the grant shall vest on February 9, 2023 and the remaining 2/3 of the grant shall vest on February 9, 2024.
  • [F3]25% of this option shall vest and become exercisable on February 9, 2022, with the remainder vesting in 12 equal quarterly installments thereafter

Issuer

Axcella Health Inc.

CIK 0001633070

Entity typeother

Related Parties

1
  • filerCIK 0001774663

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:27 PM ET
Size
7.9 KB